227 related articles for article (PubMed ID: 20734172)
1. Augmentation enterocystoplasty in overactive bladder: is there still a role?
Reyblat P; Ginsberg DA
Curr Urol Rep; 2010 Nov; 11(6):432-9. PubMed ID: 20734172
[TBL] [Abstract][Full Text] [Related]
2. Bladder Augmentation (Enterocystoplasty): the Current State of a Historic Operation.
Budzyn J; Trinh H; Raffee S; Atiemo H
Curr Urol Rep; 2019 Jul; 20(9):50. PubMed ID: 31342172
[TBL] [Abstract][Full Text] [Related]
3. A robotic approach to clamshell augmentation enterocystoplasty.
Ho NX; Nambiar A
Ann R Coll Surg Engl; 2023 Nov; 105(8):777-780. PubMed ID: 37642086
[TBL] [Abstract][Full Text] [Related]
4. Overactive bladder syndrome - management and treatment options.
Arnold J; McLeod N; Thani-Gasalam R; Rashid P
Aust Fam Physician; 2012 Nov; 41(11):878-83. PubMed ID: 23145420
[TBL] [Abstract][Full Text] [Related]
5. An overview of treatment of overactive bladder syndrome in women.
Allahdin S; Oo N
J Obstet Gynaecol; 2012 Apr; 32(3):217-21. PubMed ID: 22369391
[TBL] [Abstract][Full Text] [Related]
6. [Management of overactive bladder in women].
Peyronnet B; Rigole H; Damphousse M; Manunta A
Prog Urol; 2015 Nov; 25(14):877-83. PubMed ID: 26169251
[TBL] [Abstract][Full Text] [Related]
7. The management of overactive bladder refractory to medical therapy.
Robinson D; Giarenis I; Cardozo L
Maturitas; 2013 May; 75(1):101-4. PubMed ID: 23415926
[TBL] [Abstract][Full Text] [Related]
8. Actual treatment of overactive bladder and urge urinary incontinence.
Cornu JN
Minerva Urol Nefrol; 2013 Mar; 65(1):21-35. PubMed ID: 23538308
[TBL] [Abstract][Full Text] [Related]
9. Overactive Bladder.
White N; Iglesia CB
Obstet Gynecol Clin North Am; 2016 Mar; 43(1):59-68. PubMed ID: 26880508
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiology of refractory overactive bladder.
Chen LC; Kuo HC
Low Urin Tract Symptoms; 2019 Sep; 11(4):177-181. PubMed ID: 30900373
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin injections for adults with overactive bladder syndrome.
Duthie JB; Vincent M; Herbison GP; Wilson DI; Wilson D
Cochrane Database Syst Rev; 2011 Dec; (12):CD005493. PubMed ID: 22161392
[TBL] [Abstract][Full Text] [Related]
12. [Therapy-refractory overactive bladder: alternative treatment approaches].
Knüpfer S; Hamann M; Naumann CM; Melchior D; Jünemann KP
Urologe A; 2011 Jul; 50(7):806-9. PubMed ID: 21725649
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of neurogenic detrusor hyperactivity: enterocystoplasty].
Game X; Karsenty G; Chartier-Kastler E; Ruffion A
Prog Urol; 2007 May; 17(3):584-96. PubMed ID: 17622095
[TBL] [Abstract][Full Text] [Related]
14. Augmentation cystoplasty in the patient with neurogenic bladder.
Cheng PJ; Myers JB
World J Urol; 2020 Dec; 38(12):3035-3046. PubMed ID: 31511969
[TBL] [Abstract][Full Text] [Related]
15. Vaginal laser for overactive bladder syndrome.
Charalampous I; Tailor VK; Digesu A
Int Urogynecol J; 2020 Aug; 31(8):1515-1517. PubMed ID: 32399906
[TBL] [Abstract][Full Text] [Related]
16. Refractory overactive bladder: Beyond oral anticholinergic therapy.
Glinski RW; Siegel S
Indian J Urol; 2007 Apr; 23(2):166-73. PubMed ID: 19675795
[TBL] [Abstract][Full Text] [Related]
17. [The new era in the pharmacological treatment of overactive bladder (OAB): mirabegron--a new selective beta3agonist].
Rechberger T; Kulik-Rechberger B; Miotła P; Wróbel A
Ginekol Pol; 2014 Mar; 85(3):214-9. PubMed ID: 24783434
[TBL] [Abstract][Full Text] [Related]
18. Management of refractory overactive bladder.
Giarenis I; Cardozo L
Minerva Ginecol; 2013 Feb; 65(1):41-52. PubMed ID: 23412019
[TBL] [Abstract][Full Text] [Related]
19. Understanding the elements of overactive bladder: questions raised by the EPIC study.
Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
[TBL] [Abstract][Full Text] [Related]
20. Overactive bladder.
Kavia R; Mumtaz F
J R Soc Promot Health; 2005 Jul; 125(4):176-9. PubMed ID: 16094929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
